Interferon alfa-2b biosimilar (Pooyesh Darou Pharmaceuticals)

干扰素α-2b生物类似药 (Pooyesh Darou Pharmaceuticals)

Report date: 2023/05/05 17:35:05

Base Information

Drug NameInterferon alfa-2b biosimilar (Pooyesh Darou Pharmaceuticals)
Drug Alias Name干扰素α-2b生物仿制药 (Pooyesh Darou Pharmaceuticals)PDferon-B
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple MyelomaMelanomaMalignant Carcinoid Syndrome +[7] 
Global Approved IndicationsMultiple MyelomaMelanomaMalignant Carcinoid Syndrome +[7] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIran
Original Approved Date2012/09/01
Country/TerritoryIran
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPooyesh Darou
China Registration ClassN/A

Develop Information

Active CompaniesPooyesh Darou
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaMelanomaMalignant Carcinoid Syndrome +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A